JAMA Clinical Reviews podcast

An Overview of Amyotrophic Lateral Sclerosis

0:00
17:34
Rewind 15 seconds
Fast Forward 15 seconds

Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Ravits, MD, of UC San Diego School of Medicine joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of ALS.

Related Content:

More episodes from "JAMA Clinical Reviews"